Navigation Links
Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology
Date:2/25/2009

10-Year Study Highlights Trabecular Metal Technology's Clinical Success Over Traditional Metal Implants

WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedic industry, today announced that data from an independent 10-year Trabecular Metal(TM) Technology comparative clinical study demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology. The study found bone-to-implant gap-filling and positive clinical outcomes up to 10 years after total hip arthroplasty (THA) using products made with Zimmer's Trabecular Metal Technology.

"This study reaffirms the positive clinical outcomes associated with using Trabecular Metal technology," commented Cheryl Blanchard, PhD, Zimmer's Senior Vice President, Research and Development, and Chief Scientific Officer. "Unique to Zimmer, Trabecular Metal technology allows for highly porous metal implants with flexibility very similar to cancellous bone."

The study, to be published in the Journal of Arthroplasty, followed 143 patients for up to 10 years post-THA. Findings indicate that Trabecular Metal monoblock implants result in a marked reduction in metallic and polyethylene debris and maximize the area available for bone in-growth. Further, the researchers observed a zero revision rate for aseptic loosening throughout the duration of the study and no incidence of implant migration and no radiographic evidence of gross polyethylene wear as measured digitally with (EBRA) Ein-Bild-Rontgen-Analyse.

"It is important to note that this study addresses concerns that have not been previously well characterized. It provides invaluable information about these mid-term outcomes after total hip arthroplasty and the potential adva
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
2. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
3. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
4. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
5. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
6. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
7. 10-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs
8. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
9. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
10. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
11. Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... WASHINGTON , July 23, 2014  Nearly 8,000 ... for Cardinal Health,s annual Retail Business Conference (RBC), ... & Convention Center. This year,s event encourages pharmacists to ... in their communities and for their future. ... pharmacy owners to network with their peers and learn ...
(Date:7/23/2014)... July 23, 2014  The management team at ... will hold a conference call on July 31, ... quarter ended June 30, 2014.  The call details ... , 8:30 am EDTDial-in numbers: , Toll free: ... 317-0790Webcast (live & archive): , www.columbialabs.com , ...
(Date:7/23/2014)... , July 23, 2014 This September ... in Las Vegas for ... by educator, author, forward thinker and private practitioner Dr. ... experts together to candidly discuss clinical and practice management ... event is a unique opportunity to welcome fresh thinking ...
Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... FOUNTAIN HILLS, Ariz., Sept. 23 Sunridge International ... today that it has shipped its first order ... for several Middle Eastern countries.  AME plans to ... throughout the region, while simultaneously conducting a short ...
... 23 Reportlinker.com announces that a new market ... Bayer Schering Pharma AG: PharmaVitae Profile ... Introduction This analysis examines the historical ... prescription pharma sector. The profile encompasses global company ...
Cached Medicine Technology:Sunridge Ships First Order to the Middle East 2Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile 2Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile 3Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile 4Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile 5Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile 6
(Date:7/23/2014)... patients arriving at the emergency department, the drug ... for rapid, life-saving intubation, despite decades-old studies that ... of a systematic review of 10 recent studies ... "wonder drug" are published online in Annals ... Ketamine on Intracranial and Cerebral Perfusion Pressure and ...
(Date:7/23/2014)... 23, 2014 AidJoy is delighted to announce ... Zen on September 5, 2014 from 7:00 to ... supporters are expected to attend this semi-formal event. , "We ... the past six years," says Jess Dennis, Director of Operations ... reflect on this moment in AidJoy’s history before we launch ...
(Date:7/23/2014)... Dallas, Texas (PRWEB) July 23, 2014 ... to 2020?, provides key market data on the ... provides value, in millions of US dollars, and ... US dollars), within market categories Cardiac Valve Repairs ... company shares and distribution shares data for each ...
(Date:7/23/2014)... (July 23, 2014) Statins, a class of drugs ... patient,s risk of developing Barrett,s esophagus, according to a ... , the official journal of the American Gastroenterological Association. ... with statin use. , "Patients who received statins had ... Barrett,s esophagus compared to non-users," said study author Hashem ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 With ... the leasing and financing company LeaseQ announced that ... server based software sector, they still see robust ... , To learn more about technology equipment leasing, ... and CEO of LeaseQ was quoted as saying, ...
Breaking Medicine News(10 mins):Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3
... Osteoporosis Foundation has estimated that nearly 55 percent of ... a disease of porous and brittle bones// that causes ... among Americans has been found to contribute to lower ... conducted by Katherine Tucker, PhD, director of the Epidemiology ...
... lasting modifications in the brain metabolism and blood flow ... confusion in several cancer survivors. , ,The ... Los Angeles, revealed inferior metabolism in the important region ... chemotherapy 5-10 years ago.,A spike in blood flow to ...
... declared as Breast Cancer Awareness Month and with that ... shops//. The campaign for raising funds towards breast ... cosmetics and teddy bears, as well as major charity ... ,The Boobie-Thon that has been running annually for ...
... against polio is far from over in Bihar with the ... covered in the June-July immunisation drive this year//. ,Eight ... the drive.Two new polio cases were detected in Jehanand, while ... district has also four new cases of polio, an official ...
... cancer, such as radiotherapy, surgery and drugs as well ... vary throughout the EU, according to a study published ... 3 October 2006. Access to information is also said ... survey published in Medical OncologyStatus in Europe is a ...
... children need an hour of daily physical exercise for their ... at Glasgow University studied 545 children at 36 nurseries in ... the recommended adult level of exercise - 30 minutes, three ... ,But this activity was not enough to affect ...
Cached Medicine News:Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 3Health News:Chemotherapy causes mental fog 2Health News:All in the Name of ‘Breast Cancer Awareness 2
Coronary angiographic catheter...
The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
Used to negotiate tortuous vessels....
The Emerald Guidewire is intended for percutaneous introduction of catheters....
Medicine Products: